Back to discover
Drug
Trichlorosucrose
In clinical developmentEmerging researchEarly-to-mid development
Also known as SUCRALOSE.
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Clinical trial2019-02-01Primary completion · ClinicalTrials.gov
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Trichlorosucrose
Aliases & brands
SUCRALOSE
RxNorm CUI
1439115
ChEMBL ID
CHEMBL3185084
UNII
96K6UQ3ZD4
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY1
registered trials across all phases
1
Discontinued
PHASE DISTRIBUTIONn = 1
Phase 21
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Oxidative Stress1
Journals, researchers & institutions
Top journals
- PloS one1
Leading researchers
- Dodiya HB1
- Estes JD1
- Forsyth CB1
- Jaglin JA1
- Keshavarzian A1
- Kordower JH1
- Shaikh M1
- Shannon KM1
Leading institutions
free-text, unnormalised
- Rush University Medical Center1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Trichlorosucrose in the shared literature.
2 shared diseases1 shared paper
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials